Arietta 750 Ultrasound Software Version: V1.0.0 through V2.1.3

FDA Device Recall #Z-0189-2022 — Class II — October 14, 2021

Recall Summary

Recall Number Z-0189-2022
Classification Class II — Moderate risk
Date Initiated October 14, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm FujiFilm Healthcare Americas Corporation
Location Twinsburg, OH
Product Type Devices
Quantity 15 units

Product Description

Arietta 750 Ultrasound Software Version: V1.0.0 through V2.1.3

Reason for Recall

Diagnostic ultrasound system with the specified software version and used in conjunction with a Fujifilm (formally Hitachi) transducer does not display the measurement results correctly with two cardiology measurement functions: Mitral Regurgitation Flow (MR Flow) Measurement; Mitral Valve (MV) Measurement. In addition there is an error in the instruction manual.

Distribution Pattern

Nationwide

Lot / Code Information

Serial Numbers: G3075073 (01)04562122959841(11)201214(21)G3075073; G3110777 (01)04562122959841(11)210421(21)G3110777; G3110771 (01)04562122959841(11)210421(21)G3110771; G3113780 (01)04562122959841(11)210510(21)G3113780; G3113778 (01)04562122959841(11)210510(21)G3113778; G3113779 (01)04562122959841(11)210510(21)G3113779; G3113777 (01)04562122959841(11)210510(21)G3113777; G3071857 (01)04562122959841(11)210420(21)G3071857; G3108384 (01)04562122959841(11)210402(21)G3108384; G3114220 (01)04562122959841(11)210510(21)G3114220; G3110776 (01)04562122959841(11)210421(21)G3110776; G3108385 (01)04562122959841(11)210402(21)G3108385; G3114223 (01)04562122959841(11)210518(21)G3114223; G3108401 (01)04562122959841(11)210420(21)G3108401; G3114959 (01)04562122959841(11)210524(21)G3114959

Other Recalls from FujiFilm Healthcare Americas Corporation

Recall # Classification Product Date
Z-1299-2026 Class II FDR Visionary Suite; Model Number: CH-200; Ve... Jan 9, 2026
Z-0044-2026 Class II FDR Visionary Suite, CH-200 Model/Version Numb... Sep 15, 2025
Z-2219-2025 Class II ASPRIRE Cristalle Mammography System (cleared u... Jun 11, 2025
Z-1407-2025 Class II Synapse PACS Software Version 7.4.x; Software V... Feb 11, 2025
Z-1884-2024 Class II Noblus AC Adapter used with the Noblus Ultrasou... Apr 11, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.